United States Glucagon like peptide-1 (GLP-1) agonists Market Report 2016

October 2016 | 109 pages | ID: U381ED410E1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Glucagon like peptide-1 (GLP-1) agonists

Revenue, means the sales value of Glucagon like peptide-1 (GLP-1) agonists

This report studies sales (consumption) of Glucagon like peptide-1 (GLP-1) agonists in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novo Nordisk
• AstraZeneca
• Eli Lilly
• GSK
• Sanofi
• Bristol-Myers Squibb
• Amylin

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Exenatied
• Liraglutide
• Lixisenatide
• Abliglutide
• Dulaglutide

Split by applications, this report focuses on sales, market share and growth rate of Glucagon like peptide-1 (GLP-1) agonists in each application, can be divided into

• Hospital
• Pharmacy
• Application 3

Contents

United States Glucagon like peptide-1 (GLP-1) agonists Market Report 2016

1 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERVIEW

1.1 Product Overview and Scope of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
  1.2.11 Exenatied
  1.2.12 Liraglutide
  1.2.13 Lixisenatide
  1.2.14 Abliglutide
  1.2.15 Dulaglutide
1.3 Application of Glucagon like peptide-1 (GLP-1) agonists
  1.3.11 Hospital
  1.3.12 Pharmacy
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Glucagon like peptide-1 (GLP-1) agonists (2011-2021)
  1.4.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2021)
  1.4.2 United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)

2 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS COMPETITION BY MANUFACTURERS

2.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Glucagon like peptide-1 (GLP-1) agonists Average Price by Manufactures (2015 and 2016)
2.4 Glucagon like peptide-1 (GLP-1) agonists Market Competitive Situation and Trends
  2.4.1 Glucagon like peptide-1 (GLP-1) agonists Market Concentration Rate
  2.4.2 Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Type (2011-2016)
3.2 United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2011-2016)
3.3 United States Glucagon like peptide-1 (GLP-1) agonists Price by Type (2011-2016)
3.4 United States Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Type (2011-2016)

4 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales and Market Share by Application (2011-2016)
4.2 United States Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURERS PROFILES/ANALYSIS

5.1 Novo Nordisk
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 AstraZeneca
  5.2.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Eli Lilly
  5.3.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 GSK
  5.4.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi
  5.5.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Bristol-Myers Squibb
  5.6.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Amylin
  5.7.2 Glucagon like peptide-1 (GLP-1) agonists Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview

6 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MANUFACTURING COST ANALYSIS

6.1 Glucagon like peptide-1 (GLP-1) agonists Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET FORECAST (2016-2021)

10.1 United States Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue Forecast (2016-2021)
10.2 United States Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Type (2016-2021)
10.3 United States Glucagon like peptide-1 (GLP-1) agonists Sales Forecast by Application (2016-2021)
10.4 Glucagon like peptide-1 (GLP-1) agonists Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon like peptide-1 (GLP-1) agonists
Table Classification of Glucagon like peptide-1 (GLP-1) agonists
Figure United States Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type in 2015
Figure Exenatied Picture
Figure Liraglutide Picture
Figure Lixisenatide Picture
Figure Abliglutide Picture
Figure Dulaglutide Picture
Table Application of Glucagon like peptide-1 (GLP-1) agonists
Figure United States Sales Market Share of Glucagon like peptide-1 (GLP-1) agonists by Application in 2015
Figure Hospital Examples
Figure Pharmacy Examples
Figure United States Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate (2011-2021)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate (2011-2021)
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales of Key Manufacturers (2015 and 2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers
Figure 2016 Glucagon like peptide-1 (GLP-1) agonists Sales Share by Manufacturers
Table United States Glucagon like peptide-1 (GLP-1) agonists Revenue by Manufacturers (2015 and 2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers
Table 2016 United States Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Manufacturers
Table United States Market Glucagon like peptide-1 (GLP-1) agonists Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Glucagon like peptide-1 (GLP-1) agonists Average Price of Key Manufacturers in 2015
Figure Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 3 Manufacturers
Figure Glucagon like peptide-1 (GLP-1) agonists Market Share of Top 5 Manufacturers
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales by Type (2011-2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales Share by Type (2011-2016)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Sales Market Share by Type in 2015
Table United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Market Share by Type (2011-2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Glucagon like peptide-1 (GLP-1) agonists by Type (2011-2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Price by Type (2011-2016)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Type (2011-2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales by Application (2011-2016)
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales Market Share by Application (2011-2016)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Sales Market Share by Application in 2015
Table United States Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Application (2011-2016)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Sales Growth Rate by Application (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table GSK Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Amylin Basic Information List
Table Amylin Glucagon like peptide-1 (GLP-1) agonists Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amylin Glucagon like peptide-1 (GLP-1) agonists Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Glucagon like peptide-1 (GLP-1) agonists
Figure Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
Figure Glucagon like peptide-1 (GLP-1) agonists Industrial Chain Analysis
Table Raw Materials Sources of Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
Table Major Buyers of Glucagon like peptide-1 (GLP-1) agonists
Table Distributors/Traders List
Figure United States Glucagon like peptide-1 (GLP-1) agonists Production and Growth Rate Forecast (2016-2021)
Figure United States Glucagon like peptide-1 (GLP-1) agonists Revenue and Growth Rate Forecast (2016-2021)
Table United States Glucagon like peptide-1 (GLP-1) agonists Production Forecast by Type (2016-2021)
Table United States Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast by Application (2016-2021)